US Broker Ratings

Danaher Corporation (DHR) Stock Analysis: Exploring a Potential 11.93% Upside with Strong Buy Ratings

Danaher Corporation (NYSE: DHR), a titan within the healthcare sector, has consistently demonstrated its prowess in the diagnostics and research industry. With a robust market capitalization..

AstraZeneca PLC (AZN) Stock Analysis: Promising Growth with a 6.56% Potential Upside

AstraZeneca PLC (AZN), a heavyweight in the healthcare sector, continues to capture investor attention with its robust pipeline and strategic collaborations. As a leading biopharmaceutical company..

UnitedHealth Group (UNH) Stock Analysis: Navigating Healthcare’s Robust Performer with a 10.53% Upside Potential

UnitedHealth Group Incorporated (NYSE: UNH) is a titan in the healthcare sector, commanding a market capitalization of $322.71 billion. As a diversified healthcare company, it operates..

Emergent BioSolutions Inc. (EBS) Stock Analysis: Is the 11.66% Upside Worth the Risk?

Emergent BioSolutions Inc. (NYSE: EBS), the Maryland-based life sciences company, is drawing attention from investors with its potential upside of 11.66%. Known for its extensive portfolio..

Rapport Therapeutics, Inc. (RAPP): Investor Outlook with an 87% Potential Upside

Rapport Therapeutics, Inc. (NASDAQ: RAPP) is rapidly making waves in the biotechnology sector with its focus on developing breakthrough therapies for central nervous system (CNS) disorders...

AngioDynamics, Inc. (ANGO) Stock Analysis: Exploring an 81.88% Potential Upside

AngioDynamics, Inc. (NASDAQ: ANGO), a key player in the medical technology sector, has caught the eye of investors with its compelling growth potential. With a market..

Enhabit, Inc. (EHAB) Stock Analysis: Exploring a 5.39% Potential Upside in Healthcare

As Enhabit, Inc. (EHAB) continues to solidify its presence in the healthcare sector, investors are closely watching its performance within the medical care facilities industry. Based..

InnovAge Holding Corp. (INNV) Stock Analysis: Navigating Healthcare with Revenue Growth and a Cautious Outlook

InnovAge Holding Corp. (NASDAQ: INNV), operating within the healthcare sector as a provider of medical care facilities, has been capturing attention with its distinct approach to..

PureTech Health plc (PRTC): Biotechnology Gem with a Staggering Revenue Growth of 542.70%

PureTech Health plc (PRTC) is emerging as a standout player in the biotechnology sector, captivating the attention of investors with its remarkable revenue growth and cutting-edge..

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Exploring a Potential 81% Upside

Treace Medical Concepts, Inc. (NASDAQ: TMCI), a player in the healthcare sector’s medical devices industry, is making waves with its innovative solutions for bunion correction and..

Castle Biosciences, Inc. (CSTL) Stock Analysis: A Healthcare Innovator with Strong Buy Ratings and 9.13% Upside Potential

Castle Biosciences, Inc. (NASDAQ: CSTL) stands out in the healthcare sector, specifically within the diagnostics and research industry. Based in Friendswood, Texas, and boasting a market..

Prothena Corporation plc (PRTA) Stock Analysis: Evaluating a Potential 96.65% Upside

Prothena Corporation plc (NASDAQ: PRTA), a biotechnology company based in Dublin, Ireland, is gaining attention in the healthcare sector with a notable potential upside of nearly..

Dianthus Therapeutics, Inc. (DNTH) Stock Analysis: Exploring a Potential 23% Upside in the Biotech Sector

Dianthus Therapeutics, Inc. (NASDAQ: DNTH), a clinical-stage biotechnology company, has been making waves in the biotech sector with its innovative approach to treating severe autoimmune and..

Celcuity Inc. (CELC) Stock Analysis: Exploring the Biotechnology Innovator’s Growth Potential

Celcuity Inc. (NASDAQ: CELC), a clinical-stage biotechnology company, stands at the forefront of developing targeted therapies for the treatment of solid tumors. With a market capitalization..

Owens & Minor, Inc. (OMI): Investor Outlook Reveals 94% Potential Upside Amidst Challenging Valuation

Owens & Minor, Inc. (NYSE: OMI), a pivotal player in the U.S. healthcare landscape, operates within the medical distribution industry, focusing on providing comprehensive healthcare solutions...

Kamada Ltd. (KMDA) Stock Analysis: Exploring a 62.91% Upside Potential in the Healthcare Sector

Kamada Ltd. (NASDAQ: KMDA), an Israeli-based biopharmaceutical company, is capturing attention in the healthcare sector with its robust portfolio of plasma-derived protein therapeutics and a promising..

AtaiBeckley Inc. (ATAI) Stock Analysis: A Biotech Gem with Over 200% Upside Potential

AtaiBeckley Inc. (NASDAQ: ATAI), a burgeoning player in the biotechnology sector, has captured the attention of investors with its robust pipeline and promising financial outlook. Specializing..

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: 74% Potential Upside Sparks Investor Interest

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) is making waves in the biotechnology sector, not just for its innovative approach to cancer resistance therapies but also for its..

Autolus Therapeutics plc (AUTL) Investor Outlook: Exploring a Potential 511.84% Upside

For investors seeking high-risk, high-reward opportunities in the biotech sector, Autolus Therapeutics plc (NASDAQ: AUTL) offers a fascinating proposition with its substantial potential upside of 511.84%...

Abivax SA (ABVX): Investor Outlook on Potential 23.51% Upside and Growing Analyst Confidence

Abivax SA (ABVX), a promising player in the biotechnology sector, has caught the attention of investors with a potential upside of 23.51%, driven by strong analyst..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds